???global.info.a_carregar???
My career as biomedical researcher started in 2014, when I enrolled in Health Biotechnologies course as BSc degree. During these three years I had the opportunity to get in touch for the first time with lab work and the research field that contributed to broadening my curiosity and strengthening my passion for cellular and molecular biology. My one-year-BCs internship focused on the study of the role of microRNAs and other non-coding RNAs in thyroid tumorigenesis. Later, during my MSc I changed my research topic, focusing on genetic diseases. In particular, I studied the role of CFTR in Cystic Fibrosis (CF). In the beginning I deepened the pre- and post-transcriptional regulation of CFTR gene. Then, I expanded my knowledge towards the development of diagnostic techniques and the investigation of possible therapeutic strategies for CF, mainly based on CRISPR/Cas approaches. Lastly, my PhD in Molecular Medicine and Medical Biotechnology at the University of Naples (Italy), was crucial to further improve my technical skills and especially my critical thinking. During this period, I not only investigated personalized therapeutic strategies based on ex vivo CF-cell models, but I also gave my contribute to different scientific projects, on different topics, that allowed me to have a multidisciplinary approach to research. My PhD project, for instance, was based on the development of optical biosensors as new diagnostic tools for a first-level, rapid and economical screening of women with endometrial cancer. Additionally, I partecipated in the characterization of a new putative therapeutic target for endometrial cancer and leukemia at the University of Roehampton, London (UK), where I spent six months in 2022 as a visiting PhD student. Currently, I am a Postdoc Researcher at the University of Lisbon, within the Biosystems and Integrative Sciences Institute (BioISI). The project I’m working on, funded by Cystic Fibrosis Foundation, is based on the development of a novel split-ABE tool that allows temporospatial control of the editing as a way to reduce off-target/bystander effects (main limitation in the potential use of base editing).
Identificação

Identificação pessoal

Nome completo
Immacolata Zollo

Nomes de citação

  • Zollo, Immacolata
  • Zollo, I.

Identificadores de autor

Ciência ID
2B1D-1AA7-1F21
ORCID iD
0009-0006-1021-9550
Scopus Author Id
57226029052

Endereços de correio eletrónico

  • izollo@ciencias.ulisboa.pt (Profissional)
  • immacolata.zollo@gmail.com (Pessoal)

Moradas

  • Faculdade de Ciências da Universidade de Lisboa, Campo Grande - Edifício C8, Gabinete 8.4.55, 1749-016, Lisbon, Lisbon, Portugal (Profissional)

Domínios de atuação

  • Ciências Médicas e da Saúde - Biotecnologia Médica
  • Ciências Naturais - Ciências Biológicas - Biologia Celular
  • Ciências Naturais - Ciências Biológicas - Biologia Molecular
  • Ciências Médicas e da Saúde - Biotecnologia Médica - Diagnóstico e Terapias de Base Genética
  • Ciências Médicas e da Saúde - Medicina Básica - Imunologia
  • Ciências Médicas e da Saúde - Ciências da Saúde - Doenças Infeciosas

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português Utilizador elementar (A2) Utilizador independente (B1) Utilizador elementar (A2) Utilizador independente (B1)
Italiano (Idioma materno)
Formação
Grau Classificação
2019/11 - 2023/04/28
Concluído
Molecular Medicine and Medical Biotechnology (Dottorato di Ricerca)
Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Itália
"The role of biomarkers in Endometrial Cancer: first steps towards large-scale screening and personalized therapy" (TESE/DISSERTAÇÃO)
Approved with final grade of Excellent
2019/10/25
Concluído
Medical Biotechnology (Laurea Magistrale)
Università degli Studi di Napoli Federico II, Itália
"CRISPR/Cas9: single helper-dependent adenoviral vector as novel delivery system in Cystic Fibrosis" (TESE/DISSERTAÇÃO)
110/110 summa cum laude with a special mention for the career
2017/09/27
Concluído
Health Biotechnologies (Bachelor)
Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Itália
"Analysis of RP5-1024C24.1 effect on cell migration through transwell assay" (TESE/DISSERTAÇÃO)
110/110 summa cum laude
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2023/09/11 - Atual Pós-doutorado (Investigação) Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas, Portugal
2018/03 - 2019/10 Estagiário de Investigação (Investigação) Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Itália
2016/10 - 2017/09 Estagiário de Investigação (Investigação) Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Itália

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2019/11 - 2023/04 PhD Student Università degli Studi di Napoli Federico II Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Itália
CEINGE-Biotecnologie Avanzate Franco Salvatore, Itália
2022/07 - 2022/12 Visiting PhD Student University of Roehampton, Reino Unido
Projetos

Bolsa

Designação Financiadores
2023/09/11 - Atual Temporal-Spatial CRISPR Base Editing to Identify Target Cells for CFTR Repair
UIDB/04046/2020
Bolseiro de Pós-Doutoramento
FCiênciasID Associação para a Investigação e Desenvolvimento de Ciências, Portugal

Universidade de Lisboa Instituto de Biossistemas e Ciências Integrativas, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Universidade do Minho, Portugal

Universidade de Trás-os-Montes e Alto Douro, Portugal
Fundação para a Ciência e a Tecnologia

Cystic Fibrosis Foundation
Em curso
2019/11 - 2023/02 The role of biomarkers in Endometrial Cancer: first steps towards large- scale screening and personalized therapy
DOT1318092
Bolseiro de Doutoramento
Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca
Concluído

Outro

Designação Financiadores
2021 - 2023 Theratyping of Cystic Fibrosis
2022FRSS2H
Investigador
Governo Italiano Ministero dell'Istruzione dell'Universita e della Ricerca
2021 - 2022 CEINGE Task Force COVID-19
FESR 2014/2020
Investigador
Regione Campania
2020 - 2021 Peptide-nucleic acids as potential CFTR amplifier molecules for cystic fibrosis treatment
FFC#1/2020
Investigador
Italian Cystic Fibrosis Research Foundation
Produções

Publicações

Artigo em revista
  1. Esposito, Speranza; Zollo, Immacolata; Villella, Valeria Rachela; Scialò, Filippo; Giordano, Sonia; Esposito, Maria Valeria; Salemme, Nunzia; et al. "Identification of an ultra-rare Alu insertion in the CFTR gene: Pitfalls and challenges in genetic test interpretation". Clinica Chimica Acta 558 (2024): 118317. http://dx.doi.org/10.1016/j.cca.2024.118317.
    10.1016/j.cca.2024.118317
  2. Kleinfelder, Karina; Lotti, Virginia; Eramo, Adriana; Amato, Felice; Lo Cicero, Stefania; Castelli, Germana; Spadaro, Francesca; et al. "In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells". iScience 26 11 (2023): 108180. http://dx.doi.org/10.1016/j.isci.2023.108180.
    10.1016/j.isci.2023.108180
  3. Lo Cicero, Stefania; Castelli, Germana; Blaconà, Giovanna; Bruno, Sabina Maria; Sette, Giovanni; Pigliucci, Riccardo; Villella, Valeria Rachela; et al. "Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients". Respiratory Research 24 1 (2023): http://dx.doi.org/10.1186/s12931-023-02535-x.
    10.1186/s12931-023-02535-x
  4. Lo Cicero, Stefania; Castelli, Germana; Blaconà, Giovanna; Bruno, Sabina Maria; Sette, Giovanni; Pigliucci, Riccardo; Villella, Valeria Rachela; et al. "L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients". Respiratory Research 24 1 (2023): http://dx.doi.org/10.1186/s12931-023-02516-0.
    10.1186/s12931-023-02516-0
  5. Passariello, Margherita; Esposito, Speranza; Manna, Lorenzo; Rapuano Lembo, Rosa; Zollo, Immacolata; Sasso, Emanuele; Amato, Felice; De Lorenzo, Claudia. "Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays". International Journal of Molecular Sciences 24 12 (2023): 10053. http://dx.doi.org/10.3390/ijms241210053.
    10.3390/ijms241210053
  6. Cortese, Paolo; Amato, Felice; Davino, Antonio; De Franchis, Raffaella; Esposito, Speranza; Zollo, Immacolata; Di Domenico, Marina; et al. "The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy". Cells 12 11 (2023): 1447. http://dx.doi.org/10.3390/cells12111447.
    10.3390/cells12111447
  7. Berni Canani, Roberto; Comegna, Marika; Paparo, Lorella; Cernera, Gustavo; Bruno, Cristina; Strisciuglio, Caterina; Zollo, Immacolata; et al. "Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract". Frontiers in Pediatrics 9 (2021): http://dx.doi.org/10.3389/fped.2021.790285.
    10.3389/fped.2021.790285
  8. Berni Canani, Roberto; Comegna, Marika; Paparo, Lorella; Cernera, Gustavo; Bruno, Cristina; Strisciuglio, Caterina; Zollo, Immacolata; et al. "Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract". Frontiers in Pediatrics 9 (2021): http://dx.doi.org/10.3389/fped.2021.697390.
    10.3389/fped.2021.697390
  9. Comegna, Marika; Terlizzi, Vito; Salvatore, Donatello; Colangelo, Carmela; Di Lullo, Antonella Miriam; Zollo, Immacolata; Taccetti, Giovanni; Castaldo, Giuseppe; Amato, Felice. "Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype". Antibiotics 10 7 (2021): 828. http://dx.doi.org/10.3390/antibiotics10070828.
    10.3390/antibiotics10070828
Poster em conferência
  1. Zollo, Immacolata; Santos, Lúcia; Alves, Joana; Coroadinha, AS; T Harrison, Patrick; Carlos M. Farinha. "Development of a novel Adenine Base Editor with temporospatial control of the editing". Trabalho apresentado em 20th ECFS Basic Science Conference, 2025.
  2. Zollo, Immacolata; Santos, Lúcia; Alves, Joana; T Harrison, Patrick; Carlos M. Farinha. "CRISPR-ABE: a new strategy for the temporospatial control of editing to correct the W1282X mutation in the CFTR gene". Trabalho apresentado em 19th ECFS Basic Science Conference, 2024.
  3. Valeria Rachela Villella; Zollo, Immacolata; Speranza Esposito; Antonella Miriam Di Lullo; Monica Gelzo; Filippo Scialò; Gustavo Cernera; et al. "Ex Vivo hNEC model to predict CFTR function profile: our laboratory experience". Trabalho apresentado em XVIII Conference of the Italian Society of Cystic Fibrosis (SIFC), 2022.
  4. Monica Gelzo; Filippo Scialò; Annalisa Longobardi; Valeria Rachela Villella; Zollo, Immacolata; Speranza Esposito; Gustavo Cernera; et al. "CFTR Modulators effects on cholesterol metabolism in Cystic Fibrosis". Trabalho apresentado em XVIII Conference of the Italian Society of Cystic Fibrosis (SIFC), 2022.
  5. Speranza Esposito; Zollo, Immacolata; Filippo Scialò; Valeria Rachela Villella; Gustavo Cernera; Monica Gelzo; Federica Zarilli; Giuseppe Castaldo; Felice Amato. "Targeting Cystic Fibrosis with CRISPRa to enhance CFTR mRNA level". Trabalho apresentado em XVIII Conference of the Italian Society of Cystic Fibrosis (SIFC), 2022.
  6. Zollo, Immacolata; Scialò, Filippo; Giordano, Sonia; Salemme, Nunzia; Visconte, Feliciano; Cernera, Gustavo; Esposito, Maria Valeria; et al. "Detection and functional characterization of an ALU insertion in the CFTR gene". Trabalho apresentado em National Ph.D. Meeting, 2022.
  7. Zollo, Immacolata; Filippo Scialò; Sonia Giordano; Nunzia Salemme; Feliciano Visconte; Gustavo Cernera; Maria Valeria Esposito; et al. "Detection and functional characterization of an ALU insertion in the CFTR gene". Trabalho apresentado em 17th ECFS Basic Science Conference, 2022.
  8. Zollo, Immacolata; Filippo Scialò; Sonia Giordano; Nunzia Salemme; Feliciano Visconte; Marika Comegna; Maria Valeria Esposito; et al. "Detection and functional characterization of an ALU insertion in the CFTR gene". Trabalho apresentado em XVII Conference of the Italian Society of Cystic Fibrosis (SIFC), 2021.
  9. Marika Comegna; Federica Tricarico; Alessandra Potenza; Zollo, Immacolata; Noemi Falcone; Gustavo Cernera; Federica Zarrilli; Giuseppe Castaldo; Felice Amato. "A screening system to test novel modulator drugs of CFTR gene transcriptional regulation". Trabalho apresentado em XV Conference of the Italian Society of Cystic Fibrosis (SIFC), 2019.

Outros

Outra produção
  1. 305 Development of an adenine base editing-based strategy to allow temporospatial control of correction of W1282X-CFTR. Journal of Cystic Fibrosis. 2024. Zollo, Immacolata; Santos, Lúcia; Alves, Joana; T Harrison, Patrick; Carlos M. Farinha. http://dx.doi.org/10.1016/s1569-1993(24)01145-7.
    10.1016/s1569-1993(24)01145-7
  2. 623 Preliminary assessment of nasal and colon-derived primary cells theratyping for a personalized medicine approach in people with cystic fibrosis carrying ultra-rare genotypes. Journal of Cystic Fibrosis. 2022. Sorio, C.; Kleinfelder, K.; Amato, F.; Conti, J.; Lotti, V.; Farinazzo, A.; Baldisseri, E.; et al. http://dx.doi.org/10.1016/s1569-1993(22)01313-3.
    10.1016/s1569-1993(22)01313-3
  3. Comparative Evaluation of Nasal and Small Intestine Expression of ACE2, TMPRSS2 and ACE1 and in Children and in Adults. SSRN Electronic Journal. 2020. Canani, Roberto Berni; Comegna, Marika; Paparo, Lorella; Cernera, Gustavo; Bruno, Cristina; Strisciuglio, Caterina; Zollo, Immacolata; et al. http://dx.doi.org/10.2139/ssrn.3714641.
    10.2139/ssrn.3714641
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2025/03 Development of a novel Adenine Base Editor with temporospatial control of the editing 20th ECFS Basic Science Conference
(Lido di Camaiore, Itália)
2025/02 CRISPR-ABE: a new strategy for the temporospatial control of editing to correct the W1282X mutation in the CFTR gene 18th European Cystic Fibrosis Young Investigator Meeting (EYIM)
(Paris, França)
2024/03 CRISPR-ABE: a new strategy for the temporospatial control of editing to correct the W1282X mutation in the CFTR gene 19th ECFS Basic Science Conference
(Valletta, Malta)
2021/10 Detection and functional characterization of an ALU insertion in the CFTR gene XVII Conference of the Italian Society of Cystic Fibrosis (SIFC)
(Naples, Itália)

Participação em evento

Descrição da atividade
Tipo de evento
Nome do evento
Instituição / Organização
2022/10/25 - 2022/10/25 Participation in the symposium at The Francis Crick Institute, London, UK
Simpósio
5th Annual London Stem Cell Network symposium
The Francis Crick Institute, Reino Unido

Imperial College London, Reino Unido

King's College London, Reino Unido

University College London, Reino Unido

Queen Mary University of London, Reino Unido
2022/10/04 - 2022/10/05 Participation in the event at ExCeL Exhibition Centre, London, UK
Conferência
Drug Discovery 2022
ELRIG - European laboratory research & innovation group, Reino Unido
2022/09/20 - 2022/09/20 Workshop attendance at The Francis Crick Institute, London, UK
Oficina (workshop)
Modelling development and disease in organoids
STEMCELL Technologies Inc, Canadá
2022/09/07 - 2022/09/07 Participation in the annual event at Wellcome Collection, London, UK
Seminário
Leukemia UK Annual Event - Celebration of Life Changing Research
Leukemia UK, Reino Unido
Distinções

Prémio

2025 Young Fellows Travel Award
European Cystic Fibrosis Society, Dinamarca
2024 Young Fellows Travel Award
European Cystic Fibrosis Society, Dinamarca
2022 Best Poster Award
SIFC - Società Italiana per lo studio della Fibrosi Cistica, Itália
2021 Best Poster Award
SIFC - Società Italiana per lo studio della Fibrosi Cistica, Itália